Faculty profile

Michelle Samuel

ResearcherDalhousie University

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Dalhousie University directory, so their courses and email address may be missing. Find their university profile.

Michelle Samuel

Researcher

Dalhousie University

Halifax, Nova Scotia, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
13 publications in the last five years, latest in 2026.
Senior (last) author on 1 recent paper, a sign of leading a research group.
Principal investigator on 1 research grant (1 CIHR), most recently in 2025.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Cardiomyopathy Epidemiology Precision Medicine Prospective Cohort Ventricular Tachycardia

Latest papers

Catheter Ablation vs Sotalol or Amiodarone for Ventricular Tachycardia A Substudy of the VANISH2 Trial
Journal of the American College of Cardiology · 2026
Colchicine for cardiovascular secondary prevention: evidence from recent trials and meta-analyses.
Current opinion in cardiology · 2026
Inflammation reduction with colchicine in atherosclerotic cardiovascular disease.
European heart journal · 2026 · first author

All 13 publications

Latest funding

Secondary Prevention of Ventricular Tachycardia in Patient with Cardiomyopathies (END-VT)
CIHR · 2025 · Principal investigator
$1,017,448
COLCOT-T2D : Colchicine for Primary Prevention of Cardiovascular Events in Patients with Type 2 Diabetes
CIHR · 2020 · Co-investigator
$5,446,800

All 2 grants and awards

13 publications.

Catheter Ablation vs Sotalol or Amiodarone for Ventricular Tachycardia A Substudy of the VANISH2 Trial

Nery PB, Wells GA, Tang ASL, Parkash R, Stevenson W, Healey JS, Gula L, Nair GM, Essebag V, Rivard L

Journal of the American College of Cardiology20268 citations

DOI: 10.1016/j.jacc.2025.09.1595

Colchicine for cardiovascular secondary prevention: evidence from recent trials and meta-analyses.

Muroke V, Samuel M, Pierre R, Tardif JC

Current opinion in cardiology2026

DOI: 10.1097/hco.0000000000001343 PMID: 42681982

Inflammation reduction with colchicine in atherosclerotic cardiovascular disease.

Samuel M, Tardif JC

European heart journal2026First author

DOI: 10.1093/eurheartj/ehaf630 PMID: 40900138

Repeat ablation strategies in atrial fibrillation patients with durably isolated pulmonary veins: insights from the Netherlands Heart Registration.

Magni FT, Samuel M, Mulder BA, van der Stoel M, Hassink RJ, Trines SA, Kemme MJB, Balt JC, van der Voort PH, Luermans JGLM, de Jong JSSG, Blaauw Y

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation2026

DOI: 10.1007/s12471-026-02021-1 PMID: 41670906

Ventricular Tachycardia Cycle Length and Response to Rhythm Control Therapy Insights From the VANISH Trial

Samuel M, Parkash R, Healey JS, Nault I, Blier L, Gray C, Sapp JL

JACC: Clinical Electrophysiology20251 citationsFirst author

DOI: 10.1016/j.jacep.2025.08.025

Prediction of ventricular arrhythmias and sudden cardiac death by quantification and location of late gadolinium enhancement on cardiac magnetic resonance: a systematic review and meta-analysis.

Jensen TN, Omara S, Nielsen JC, Samuel M, van der Geest RJ, Kim WY, Zeppenfeld K

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology2025

DOI: 10.1093/europace/euaf214 PMID: 41206344

Multimorbidity and risk of atrial fibrillation in the Lifelines cohort.

van Deutekom C, Weil LI, Middeldorp ME, Samuel M, Geelhoed B, Velt MJH, Zwartkruis VW, Hanssen DJC, Van Munster BC, Oude Voshaar RC, Van Gelder IC, Rienstra M

European heart journal open2025

DOI: 10.1093/ehjopen/oeaf164 PMID: 41451244

Association between circulating biomarkers and atrial fibrillation burden in patients with paroxysmal atrial fibrillation: a subanalysis of the RACE V study.

Frausing MHJP, Rienstra M, Kronborg MB, De Melis M, Schotten U, Nielsen JC, Tieleman R, Crijns HJ, Van Gelder IC, Samuel M

Open heart2025Senior author

DOI: 10.1136/openhrt-2025-003433 PMID: 41033708

Long-term trials of colchicine for secondary prevention of vascular events: a meta-analysis.

Samuel M, Berry C, Dubé MP, Koenig W, López-Sendón J, Maggioni AP, Pinto FJ, Roubille F, Tardif JC

European heart journal2025First author

DOI: 10.1093/eurheartj/ehaf174 PMID: 40314333

Relationship between time-varying achieved HbA1c and risk of coronary artery disease events among common haptoglobin phenotype groups with type 2 diabetes: the ADVANCE study.

Cahill LE, Warren RA, Lavallée SK, Levy AP, Carew AS, Sapp J, Samuel M, Selvin E, Poulter N, Marre M, Harrap S, Mancia G, Harris K, Chalmers J, Woodward M, Rimm E

BMJ open diabetes research & care2025

DOI: 10.1136/bmjdrc-2024-004713 PMID: 40328645

Something wrong or missing on this profile? Suggest a correction

Michelle Samuel

Research

Latest papers

Latest funding

Catheter Ablation vs Sotalol or Amiodarone for Ventricular Tachycardia A Substudy of the VANISH2 Trial

Colchicine for cardiovascular secondary prevention: evidence from recent trials and meta-analyses.

Inflammation reduction with colchicine in atherosclerotic cardiovascular disease.

Repeat ablation strategies in atrial fibrillation patients with durably isolated pulmonary veins: insights from the Netherlands Heart Registration.

Ventricular Tachycardia Cycle Length and Response to Rhythm Control Therapy Insights From the VANISH Trial

Prediction of ventricular arrhythmias and sudden cardiac death by quantification and location of late gadolinium enhancement on cardiac magnetic resonance: a systematic review and meta-analysis.

Multimorbidity and risk of atrial fibrillation in the Lifelines cohort.

Association between circulating biomarkers and atrial fibrillation burden in patients with paroxysmal atrial fibrillation: a subanalysis of the RACE V study.

Long-term trials of colchicine for secondary prevention of vascular events: a meta-analysis.

Relationship between time-varying achieved HbA1c and risk of coronary artery disease events among common haptoglobin phenotype groups with type 2 diabetes: the ADVANCE study.

Secondary Prevention of Ventricular Tachycardia in Patient with Cardiomyopathies (END-VT)

COLCOT-T2D : Colchicine for Primary Prevention of Cardiovascular Events in Patients with Type 2 Diabetes

Frequent collaborators

Jean-Claude Tardif

John Sapp

Ratika Parkash

Jeff Healey

Vidal Essebag

Guy Amit

Léna Rivard